MorphoSys AG sell DirectorDealer
Summary
This prediction ended on 28.11.16 with a price of €43.86. The prediction for MorphoSys AG closed with a convincing performance of -10.94%. DirectorDealer has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 0.148% | 0.148% | 256.110% | -10.902% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by DirectorDealer for this prediction
In the thread Morphosys AG diskutieren
Director Dealing: Verkauf
Director Dealing / Insider Verkauf von Sproll, Dr. Marlies (Geschäftsführendes Organ)
- Handelstag: 12.05.16
- Volumen: 137680 €
- Meldender: Sproll, Dr. Marlies
Wir werten alle Insider Käufe aus. Dabei werden die größten Insiderkäufe und Verkäufe automatisch als Einschätzung angelegt. Mehr Informationen findest du im Profil von DirectorDealer.
Director Dealing / Insider Verkauf von Sproll, Dr. Marlies (Geschäftsführendes Organ)
- Handelstag: 12.05.16
- Volumen: 137680 €
- Meldender: Sproll, Dr. Marlies
Director Dealing / Insider Verkauf von Hostein, Jens (Geschäftsführendes Organ)
- Handelstag: 07.06.16
- Volumen: 470028 €
- Meldender: Hostein, Jens